Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

In patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban also reduced overall mortality, although there was more bleeding. After an acute coronary syndrome,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The New England journal of medicine Ročník 366; číslo 1; s. 9 - 19
Hlavní autoři:	Mega, Jessica L, Braunwald, Eugene, Wiviott, Stephen D, Bassand, Jean-Pierre, Bhatt, Deepak L, Bode, Christoph, Burton, Paul, Cohen, Marc, Cook-Bruns, Nancy, Fox, Keith A.A, Goto, Shinya, Murphy, Sabina A, Plotnikov, Alexei N, Schneider, David, Sun, Xiang, Verheugt, Freek W.A, Gibson, C. Michael
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Waltham, MA Massachusetts Medical Society 05.01.2012
Témata:	Acute Coronary Syndrome - drug therapy Acute coronary syndromes Aged Angina pectoris Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Arteriosclerosis Biological and medical sciences Bleeding Cardiology. Vascular system Cardiovascular disease Cardiovascular Diseases - epidemiology Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Cerebral infarction Coronary artery Coronary heart disease Death Double-Blind Method Drug Administration Schedule Factor Xa Inhibitors Female General aspects Heart Heart attacks Heart surgery Hemorrhage Hemorrhage - chemically induced Hemorrhage - mortality Humans Incidence Intracranial Hemorrhages - chemically induced Kaplan-Meier Estimate Male Medical sciences Middle Aged Morpholines - administration & dosage Morpholines - adverse effects Morpholines - therapeutic use Myocardial infarction Myocarditis. Cardiomyopathies Rivaroxaban Secondary Prevention Thiophenes - administration & dosage Thiophenes - adverse effects Thiophenes - therapeutic use Thrombosis Human Medicine Rivaroxaban Antithrombotic agent Cardiovascular disease Patient Acute coronary syndrome Coronary heart disease Myocardial disease
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!